Pharmacological evidence indicates that angiotensin (Ang II) converting enzyme inhibitors attenuate cardiovascular responses to sympathetic stimulation. To investigate the physiological significance of this attenuation, the pressor and heart rate responses to bilateral carotid occlusion (BCO) were studied before and after administration of captopril and again during Ang II replacement in conscious, aortic nerve-sectioned rabbits with chronically implanted carotid occluders. In the control period, BCO produced increases (p<0.05) in mean arterial pressure (MAP) In two additional series of experiments, the mechanism of the effects of captopril and Ang II were investigated. In the first series, cardiac baroreflex curves (pulse interval versus MAP) were generated by increasing or decreasing blood pressure with phenylephrine or nitroprusside (5-20 ug/kg/min i.v.). The slope of the linear region of the curve (2.9 msec/mm Hg) was not changed significantly by captopril treatment (3.1 msec/mm Hg) or Ang II replacement (3.2 msec/mm Hg), indicating that cardiac baroreflex sensitivity was not altered by blockade of the renin-angiotensin system. In the second series, the effect of captopril on the pressor response to exogenous norepinephrine (0.1-2.5 ,ug/kg/min i.v.) was tested. The response was reduced by less than 40%, indicating only a modest postsynaptic component to the action of captopril. These results provide physiological evidence for an important action of endogenous Ang II in facilitating the cardiovascular responses to sympathetic stimulation in conscious rabbits. This facilitation is not due to an action upon the baroreflex per se but results, at least in part, from a presynaptic action of Ang II. (Circulation Research 1990;66:662- 
Angiotensin II (Ang II) exerts potent effects on blood pressure (BP) via its direct vasoconstrictor action and via its effects on aldosterone secretion and sodium excretion.' The peptide can also affect BP regulation through a variety of effects on the autonomic nervous system. It acts centrally to increase sympathetic nerve activity2 and decrease vagal tone to the heart.34 It also exerts a variety of actions on the peripheral sympathetic nervous system.5 Specifically, it facilitates adrenergic func-tion by potentiating the release67 and inhibiting the reuptake8 9 of norepinephrine from sympathetic nerve terminals, by stimulating the release of catecholamines from the adrenal medulla,10'11 and by increasing vascular responsiveness to norepinephrine.'2-14 Finally, Ang II acts to reset'5 or attenuate1617 baroreceptor reflexes, and this is apparently responsible for the absence of bradycardia when BP is increased by Ang II. is evidence that converting enzyme inhibitors reset the cardiac baroreflex in a direction opposite to that produced by Ang 11.22 Thus, it appears that endogenous Ang II exerts the same effects upon the sympathetic nervous system and baroreflex as does exogenous Ang II.
Despite this progress, the physiological importance of the effects of Ang II on the sympathetic nervous system remains unclear. Many studies of the influence of endogenous Ang II on the sympathetic nervous system have been performed in anesthetized or pithed animals in which cardiovascular, endocrine, and neural function is markedly altered. Anesthesia or acute surgical stress frequently increases plasma Ang II concentration well above the normal physiological range, but in most investigations, circulating levels of Ang II were not measured. In some cases, the actions of endogenous Ang II have been explored in isolated perfused vascular beds, including the dog paw23 and rat mesenteric bed,24 but it is not clear if these experiments reflect actions of Ang II throughout the systemic circulation.
The aim of the present study was to investigate the effects of endogenous Ang II on the sympathetic nervous system in a more physiological setting. Conscious rabbits, with vascular balloon occluders chronically implanted around both carotid arteries, were used to investigate cardiovascular responses to endogenous sympathetic stimulation produced by bilateral carotid occlusion. The pressor and HR responses to carotid occlusion were examined before and after blockade of the renin-angiotensin system with the converting enzyme inhibitor captopril. The responses to carotid occlusion were subsequently studied after restoration of circulating Ang II by the infusion of a subpressor dose of Ang II. To assess a possible postsynaptic influence of Ang II, the effects of captopril treatment and subsequent Ang II replacement on the pressor and HR responses to exogenous norepinephrine were studied. Finally, the effects of converting enzyme inhibition and Ang II replacement on the cardiac baroreflex were investigated.
Materials and Methods
Sixteen male New Zealand white rabbits, 2.3-3.5 kg in body weight, were used in this study. Captopril (5 mg/kg i.v.) was injected as a 1.5-mI bolus after recovery from the third carotid occlusion performed during the control period. Twenty to 30 minutes after captopril administration, the sequence of three carotid occlusions was repeated. To test the effectiveness of the converting enzyme inhibitor, the BP response to the injection of Ang I (Peninsula Labs) as a 200-ng/kg bolus in 0.5 ml was tested before and 10-90 minutes after captopril treatment.
An intravenous infusion of Ang II at 5 ng/kg/min in 0.0136 ml/min was started after the third postcaptopril carotid occlusion. Fifteen minutes after the start of the Ang II infusion, another series of three carotid occlusions was performed. In two rabbits, the dose of Ang II was subsequently increased to approximately 10 ng/kg/min, and in a third rabbit it was increased to 25 ng/kg/min. The sequence of three occlusions was then repeated. The effect of Ang II administration was also tested in four rabbits that had not received captopril.
An arterial blood sample was collected immediately before the first occlusion in each experiment, after the third occlusion following captopril, and after the last carotid occlusion of the Ang II treatment period. In a control experiment, a rabbit received a saline bolus (1.5 ml) in place of captopril and a saline infusion (0.0136 ml/min) substituted for Ang II. Three series of three carotid occlusions were performed as just described. In another experiment, the responses to carotid occlusion were studied before and after captopril, and again during Ang II infusion as described above. The infusion of Ang II was then stopped, and the effects of carotid occlusion were studied 20, 30, and 40 minutes later. In an additional experiment in one rabbit, the responses to carotid occlusion were examined before and after captopril. After the third occlusion after captopril, phenylephrine (Neo-Synephrine, Sterling Drug, New York, New York) was infused (25 ,ug/kg/min, 0.051 ml/min i.v.) instead of Ang II. Ten minutes after the start of the phenylephrine infusion, two carotid occlusions were performed. The phenylephrine infusion was then discontinued before an infusion of Ang 11 (10 ng/kg/min) was started and the responses to three occlusions assessed as described above.
Effects of captopril and Ang II on the cardiac baroreflex. The HR-BP baroreflex was assessed by examining the relation between pulse interval and MAP in four rabbits. In these experiments, BP was lowered by intravenous infusions of sodium nitroprusside (Elkins-Sinn, Cherry Hill, New Jersey) in doses of 5, 10, and 20 ,ug/kg/min i.v. at 0.051 ml/min and was increased by infusions of phenylephrine in doses of 5, 10, and 20 ,ug/kg/min i.v. at 0.051 ml/min. Each infusion lasted 2 minutes. BP and HR were recorded continuously during the infusion of each dose, and 10 minutes was allowed between each infusion for BP and HR to return to baseline levels. After the six infusions during the control period, captopril was administered as described above. The series of six infusions was repeated 15 minutes later. Ang II was then infused (10 ng/kg/min i.v., 0.0136 ml/min), and the series of infusions was repeated for a third time.
Effects of captopril and Ang II on the pressor and heart rate responses to norepinephrine. In five rabbits, the pressor and HR responses to norepinephrine (Levophed, Sterling Drug) were studied before and after converting enzyme blockade with captopril and again during the replacement of Ang II.
After HR and BP had stabilized, 5-minute intravenous infusions of norepinephrine in doses of 0.1, 0.5, and 2.5 ,ug/kg/min (0.051 ml/min) were delivered in random order. Ten minutes was allowed for BP and HR to return to baseline between each infusion. Captopril (5 mg/kg i.v. as a 1.5 ml bolus) was injected after the last control norepinephrine infusion, and the series of three infusions was repeated 15 minutes later. An infusion of Ang 11 (10 ng/kg/min i.v., 0.0136 ml/min) was started after the last norepinephrine infusion of the captopril period. Fifteen minutes later, the responses to the three doses of norepinephrine were recorded.
Statistical Analysis
Data were analyzed using one-way and two-way analyses of variance for repeated measures and Newman-Keuls multiple range test. 28 Baroreflex curves were fitted by regression analysis using the least-squares method, and their slopes were compared statistically. For (Figure 3) . The pressor response to carotid occlusion was accompanied by an increase in HR from 255.4+16.7 to 277.1±+ 12.4 beats/min (p<0.05, Figure 2 ), an increase of 21.7+5.4 beats/min (Figure 3 ). BP and HR rapidly returned to baseline values after release of the occlusion.
Effects of Captopril
Captopril decreased baseline BP in three rabbits but had essentially no effect (<5 mm Hg) on BP in the other three (see Figure 1) . Overall, baseline MAP decreased from 79.1+2.5 to 66.4± 6.4 mm Hg (p<0.05, Figure 2 ). Baseline HR increased slightly in some rabbits, but the overall increase from 255.4+ 16.7 to 266.4+12.9 beats/min was not statistically significant. Captopril treatment greatly reduced the BP and HR responses to carotid occlusion (Figures 1-3) . MAP increased to 76.6+8.1 mm Hg (p<0.05, Figure 2 ), an increase of only 10.2±2.6 mm Hg, which was significantly less than the increase during the control period (p<0.05, Figure 3) . HR also changed little in response to carotid occlusion after captopril, reaching only 271.0+13.8 beats/min (Figure 2 ). This increase in HR of 5.0±4 beats/min was significantly less than the rise during the control period (p<0.05, Figure 3 ). (Figure 2 ). Carotid occlusion during Ang II replacement increased MAP to 100.3±11.0 mm Hg (p<0.05, Figure 2 ), and this increase of 33.0±5.7 mm Hg was significantly greater than that observed during the captopril treatment period (p<0.05, Figure 3 ). Baseline HR was also not changed significantly by Ang II replacement. Carotid occlusion during Ang II replacement increased HR from 255.3±12.5 to 275.1±7.9 beats/min (p<0.05, Figure 2 ), an increase of 19.8±7.7 beats/min (p<0.05, Figure 3 ), which was significantly greater than the HR response to carotid occlusion during the captopril period (p<0.05, Figure 3 ). Administration of Ang II in four rabbits that had not received captopril did not modify the pressor or HR responses to carotid occlusion.
In an additional experiment in two rabbits, the dose dependence of the restoration of the responses to carotid occlusion by Ang II was explored. Figure 4 demonstrates the restoration of responses to carotid occlusion after captopril treatment with two doses of Ang II, 5 and 12.5 ng/kg/min. In the control period, carotid occlusion increased MAP by 37 In four rabbits, the effects on BP and pulse interval (PI) of the infusion of three doses of phenylephrine and three doses of nitroprusside were studied before and after captopril treatment and again during Ang II infusion. The results are summarized in Figure 8 .
In the control period, MAP ranged from 60 to 119 mm Hg during the nitroprusside and phenylephrine infusion; PI ranged from 190 to 373 msec. The relation between PI and MAP could be described by the equation P1=2.94xMAP+13.1 (r=0.98, p<0.05).
After captopril treatment, MAP ranged from 42 to 113 mm Hg during the infusions of nitroprusside and phenylephrine, and PI ranged from 192 to 399 msec. The relation between PI and MAP was shifted to the left of the control baroreflex curve, whereas the slope remained essentially unchanged (PI=3. Figure 9 .
In the control period, the three doses of norepinephrine increased MAP by 3 (Figure 9 ). In contrast, the HR responses to norepinephrine were slightly but not significantly potentiated during captopril treatment.
The pressor and HR responses to norepinephrine were restored by infusion of Ang II at 10 ng/kg/min ( Figure 9 ). During the Ang II infusion, the BP and HR responses to norepinephrine were not significantly different from the responses of the control period except for the HR response to the highest dose of norepinephrine, which was less than the responses in the control and captopril periods. Discussion Bilateral carotid occlusion is an effective means of increasing sympathetic drive to the cardiovascular system and, in turn, increasing arterial BP. In rabbits this response can conveniently be increased by sectioning the aortic nerve, which eliminates the buffering input from aortic arch baroreceptors.30
In the present study in conscious, aortic nervesectioned rabbits, bilateral carotid occlusion elicited rapid and highly reproducible increases in BP and HR. These increases were maintained for the duration of the 4-minute occlusion and fell rapidly to preocclusion levels after release of the occlusion. Pressor and heart rate responses to norepineph- The inhibitory effect of captopril in the present study could have been due to inhibition of Ang II formation or to some other effect, such as decreased metabolism of bradykinin. It was clear that captopril did block Ang II formation because there was a marked reduction in plasma Ang II concentration and because the pressor response to Ang I was completely blocked. Nevertheless, to determine whether the inhibition of the responses to carotid occlusion by captopril was due to inhibition of Ang II formation, the effect of Ang II replacement was investigated. Replacement of Ang II in low, subpressor doses returned plasma Ang II concentration to its precaptopril level and fully restored the BP and HR responses to carotid occlusion. The restoration of the responses to carotid occlusion by Ang II was dependent on the dose of Ang II. In addition, the restoration of the pressor response by Ang II was shown to be reversible.
Some experiments were performed as soon as 2 days after surgery. The effect of captopril to reduce the responses to carotid occlusion could usually be demonstrated in these rabbits (and in others not included in this study) for a number of days following the initial experiment. In one rabbit in this group, however, the ability of captopril to attenuate the responses to carotid occlusion was lost several days after the first experiment. In addition, one rabbit, not included in this study, failed to respond to captopril treatment on the initial trial 2 days after surgery. However, after sodium depletion, with a regimen known to increase renin release and plasma Ang II concentration,32 both rabbits demonstrated characteristically attenuated responses to carotid occlusion after captopril administration.
One possibility that should be considered is that the blockade of the responses to carotid occlusion by captopril was simply the result of a decrease in baseline BP. If this resulted in maximal "unloading" of the carotid sinus baroreceptors, the baroreceptors would be unable to sense the further drop in carotid sinus pressure caused by carotid occlusion. However, the results indicate that another mechanism must be involved because in some rabbits the responses to carotid occlusion were markedly reduced even when baseline BP was not changed by captopril. Moreover, 35 These investigators reported that sodium depletion decreased the pressor response to carotid occlusion and that teprotide, another converting enzyme inhibitor, had no effect on the responses to carotid occlusion. They concluded that sodium depletion attenuated the pressor response to carotid occlusion via a mechanism that is independent of the actions of Ang II. It is possible that teprotide may not have the same effects as captopril.18,36 It is surprising, however, that chronic sodium depletion, which increased plasma renin activity, blunted the pressor response to carotid occlusion. This finding may reflect an additional effect of sodium depletion that could influence the cardiovascular responses to sympathetic stimulation.
Additional experiments were performed to investigate the site where and mechanism by which captopril attenuates the cardiovascular responses to carotid occlusion. One possibility was that captopril attenuated the responses by inhibiting the baroreflex. To test this possibility, cardiac baroreflex curves were generated by measuring the HR responses to increases or decreases in BP and plotting the relation between PI and MAP. A displacement of the curve to the left or right reflects a change in the "setpoint" of the baroreflex, whereas a change in slope indicates a change in baroreflex sensitivity. Captopril treatment shifted the linear region of the baroreflex curve to the left but did not change the slope of the curve ( Figure  8 ). Thus 
